Drug Profile
Research programme: oral DNA vaccines - Emergent BioSolutions
Alternative Names: Oral DNA vaccines research programme - Emergent BioSolutionsLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Emergent BioSolutions
- Class Cancer vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections; Cancer; Viral infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Bacterial-infections in United Kingdom (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in United Kingdom (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Viral-infections in United Kingdom (PO)